<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Preconception and Antenatal Care - National Guidelines</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">üè†</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="02-maternal-nutrition.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 16%;"></div>
                        </div>
                       <span class="progress-text">Section 3 of 18</span>
                    </div>
                    <a href="04-aph-and-pprom.html" class="nav-button">
                        <span class="nav-text">Next: APH & PPROM</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">PRECONCEPTION CARE</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: preconception-care -->
                <section id="preconception-care" class="content-section">
                    <h2>Introduction</h2>
                    <div class="content-card">
                        <p>Preconception care is the provision of biomedical, behavioral and social health interventions to women and couples before conception occurs (WHO, 2012). It aims at improving their health status and reducing behaviors and individual and environmental factors that contribute to poor maternal and child health outcomes. Its ultimate aim is to improve maternal and child health, in both the short and long term.</p>

                        <h3>Life course - when to intervene?</h3>
                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-062-1.jpg" alt="Figure 11: Pre-conception care" class="content-image">
                            <figcaption>Figure 11: Pre-conception care</figcaption>
                        </figure>
                        <p>Adopted from WHO 2012 Preconception care policy brief 2</p>
                        <p>Opportunities to prevent and control diseases occur at multiple stages of life; strong public health programmes that use a life-course perspective from infancy through childhood and adolescence to adulthood are needed. Preconception care contributes to these efforts. Even if preconception care aims primarily at improving maternal and child health, it brings health benefits to the adolescents, women and men, irrespective of their plans to become parents.</p>

                        <h3>Why is pre-conception care a public health concern?</h3>
                        <p>Despite advances in maternal and newborn health care, poor birth outcomes continue to be a problem in Kenya. Newborn mortality now contributes to 59% of all infant mortality rate, with prematurity, asphyxia and infection accounting for the majority of the deaths. HIV prevalence in WRA has increased to 9.2%; among youth women 15 to 24 years are 4 times more likely to be infected with HIV than men. This is also the group of women with the highest total fertility rate.</p>
                        <p>Among women of reproductive age, risks associated with poor pregnancy outcomes e.g. malaria and anemia remain prevalent; smoking, alcohol use and drug abuse are on the increase. Events in childhood/adolescence e.g. malnutrition, stunting, obesity may also lead to poor obstetric outcomes later. All of these factors could be addressed with proper health interventions prior to conception.</p>
                        <p>Although the recommended timing of the first ANC visit is before 16 weeks, most women present when it is too late to prevent the majority of serious maternal and newborn health problems. The foetus is most susceptible to developing certain problems in the first 4-10 weeks of intrauterine life. At this time many women are not even aware that they are pregnant and they are therefore unable to recognize and address the risks to their own and their baby's health, hence, the need for interventions to begin before conception.</p>
                        <p>Managing long-term health conditions includes ensuring that mental health issues, metabolic disorders and other chronic medical conditions-including obesity-are well managed and sufficiently monitored. Women should be informed regarding the effect of their condition on potential pregnancy and vice versa. Additionally, women and men taking teratogenic medications should be advised regarding effective contraception and provided with information about switching to alternative treatments when trying to conceive.</p>
                        <p>Assistance in stopping or avoiding risky behaviors includes counselling on smoking cessation, excessive alcohol intake and drug misuse. Promoting healthy behaviors covers advice regarding nutrition, folic acid and other supplements, vaccinations such as rubella, sexually transmitted infection and cervical screening, if appropriate, and reproductive planning. Healthcare providers should discuss effective contraception with individuals who do not wish to conceive in the near future.</p>

                        <h3>Target Population</h3>
                        <p>The target population for preconception care is women of reproductive age (WRA - 15 to 49 years), although men are also targeted by several components of preconception care.</p>
                        <p>At risk populations to whom special attention should be provided include teenage girls, refugees, women living in disaster prone regions, survivors of gender-based violence.</p>
                        <p>Inter sectoral collaborations with other key stakeholders including the Ministries of Education, Gender and Social Services, Internal Security and others including religious organizations, to support develop and implement guidelines aiding in preconception care.</p>

                        <h3>Objectives of Preconception Care</h3>
                        <ul class="enhanced-list">
                            <li>To provide health promotion and education to improve knowledge attitudes and behaviors of men and women with regard to pregnancy</li>
                            <li>To provide Evidence - based screening for pregnancy risks</li>
                            <li>To provide interventions to address identified risks and conditions</li>
                            <li>To achieve universal coverage of Essential Obstetric Care</li>
                        </ul>

                        <h3>Scope/focus areas</h3>
                        <p>Pre-conception care can be divided into three main focus areas:</p>
                        <ul class="enhanced-list">
                            <li>management of long-term health conditions</li>
                            <li>assistance in ceasing risky behaviors</li>
                            <li>promoting healthy behaviors.</li>
                        </ul>

                        <h3>Why Preconception Care?</h3>
                        <p>Preconception care has a positive effect on a range of health outcomes. Among others, preconception care can:</p>
                        <ul class="enhanced-list">
                            <li>Reduce maternal and child mortality</li>
                            <li>Prevent unintended pregnancies</li>
                            <li>Prevent complications during pregnancy and delivery</li>
                            <li>Prevent stillbirths, preterm birth and low birth weight</li>
                            <li>Prevent birth defects</li>
                            <li>Prevent neonatal infections</li>
                            <li>Prevent underweight and stunting</li>
                            <li>Prevent vertical transmission of HIV/STIs</li>
                            <li>Lower the risk of some forms of childhood cancers</li>
                            <li>Lower the risk of type 2 diabetes and cardiovascular disease later in life</li>
                        </ul>

                        <p>Preconception care has a positive effect on a range of health outcomes:</p>
                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-065-1.jpg" alt="Figure 12: Positive effects of pre-conception care" class="content-image">
                            <figcaption>Figure 12: Positive effects of pre-conception care</figcaption>
                        </figure>
                        <p>Adopted from WHO 2012 Preconception care policy brief.</p>
                    </div>
                </section>
                <!-- END: preconception-care -->

                <!-- START: package-of-care -->
                <section id="package-of-care" class="content-section">
                    <h2>What is the package of preconception care interventions?</h2>
                    <div class="content-card">
                        <p>Areas addressed by the preconception care package & examples of evidence-based interventions:</p>

                        <h3>Nutritional conditions</h3>
                        <ul class="enhanced-list">
                            <li>Screening for anaemia and diabetes</li>
                            <li>Supplementing iron and folic acid</li>
                            <li>Information, education and counselling</li>
                            <li>Monitoring nutritional status</li>
                            <li>Supplementing energy- and nutrient-dense food</li>
                            <li>Management of diabetes, including counselling people with diabetes mellitus</li>
                            <li>Promoting exercise</li>
                            <li>Iodization of salt</li>
                        </ul>

                        <h3>Genetic conditions</h3>
                        <ul class="enhanced-list">
                            <li>Taking a thorough family history to identify risk factors for genetic conditions</li>
                            <li>Family planning</li>
                            <li>Genetic counselling</li>
                            <li>Carrier screening and testing</li>
                            <li>Appropriate treatment of genetic conditions</li>
                            <li>Community-wide or national screening among populations at high risk</li>
                        </ul>

                        <h3>Environmental health</h3>
                        <ul class="enhanced-list">
                            <li>Providing guidance and information on environmental hazards and prevention</li>
                            <li>Protecting from unnecessary radiation exposure in occupational, environmental and medical settings</li>
                            <li>Avoiding unnecessary pesticide use/providing alternatives to pesticides</li>
                            <li>Protecting from lead exposure</li>
                            <li>Informing women of childbearing age about levels of methyl mercury in fish</li>
                            <li>Promoting use of improved stoves and cleaner liquid/gaseous fuels</li>
                        </ul>

                        <h3>Infertility/sub-fertility</h3>
                        <ul class="enhanced-list">
                            <li>Creating awareness and understanding of fertility and infertility and their preventable and unpreventable causes</li>
                            <li>Defusing stigmatization of infertility and assumption of fate</li>
                            <li>Screening and diagnosis of couples following 6-12 months of attempting pregnancy, and management of underlying causes of infertility/sub-fertility, including past STIs</li>
                            <li>Counselling for individuals/couples diagnosed with unpreventable causes of infertility/subfertility</li>
                        </ul>

                        <h3>Sexual Reproductive Health and Gender Rights</h3>
                        <ul class="enhanced-list">
                            <li>Health promotion to prevent dating violence</li>
                            <li>Providing age-appropriate comprehensive sexuality education that addresses gender equality, human rights, and sexual relations</li>
                            <li>Combining and linking economic empowerment, gender equality and community mobilization activities</li>
                            <li>Recognizing signs of Intimate Partner Violence against women</li>
                            <li>Providing comprehensive GBV care services including post-rape care, forensic management, referral and psychosocial support to victims of violence</li>
                            <li>Social Behaviour Change Communication regarding alcohol and substance abuse</li>
                        </ul>

                        <h3>Teenage, unintended and rapid successive pregnancies</h3>
                        <ul class="enhanced-list">
                            <li>Support enrolment and retention of girls in school Provide mechanisms to eradicate harmful cultural practices e.g., child marriage and coerced sex</li>
                            <li>Providing age-appropriate SRH information</li>
                            <li>Promote abstinence amongst adolescents</li>
                            <li>Provide Life skills education to adolescents including resisting coerced sex</li>
                            <li>Engaging men and boys to critically assess norms and practices regarding gender-based violence and coerced sex</li>
                            <li>Educating women and couples about the dangers to the baby and mother of short birth intervals</li>
                        </ul>

                        <h3>Sexually transmitted infections (STIs)</h3>
                        <ul class="enhanced-list">
                            <li>Providing age-appropriate SRH information</li>
                            <li>Promoting safe sex practices through individual, group and community-level behavioral interventions</li>
                            <li>Promoting condom use for dual protection against STIs and unintended pregnancies</li>
                            <li>Ensuring increased access to condoms</li>
                            <li>Screening for STIs</li>
                            <li>Increasing access to treatment and other relevant health services</li>
                        </ul>

                        <h3>HIV prevention and control</h3>
                        <ul class="enhanced-list">
                            <li>Family planning for birth spacing</li>
                            <li>Promoting safe sex practices and dual method for birth control (with condoms) and STI control</li>
                            <li>Provider-initiated HIV counselling and testing, including male partner testing</li>
                            <li>Providing antiretroviral therapy for prevention and pre-exposure prophylaxis</li>
                            <li>Providing male circumcision</li>
                            <li>Providing antiretroviral prophylaxis for women not eligible for, or not on, antiretroviral therapy to prevent mother-to-child transmission</li>
                            <li>Determining eligibility for lifelong antiretroviral therapy</li>
                        </ul>

                        <h3>Mental health</h3>
                        <ul class="enhanced-list">
                            <li>Assessing psychosocial problems</li>
                            <li>Providing educational and psychosocial counselling before and during pregnancy</li>
                            <li>Counselling, treating and managing depression in women planning pregnancy and other women of childbearing age</li>
                            <li>Strengthening community networks and promoting women's empowerment</li>
                            <li>Improving access to education for women of childbearing age</li>
                            <li>Reducing economic insecurity of women of childbearing age</li>
                        </ul>

                        <h3>Psychoactive substance use</h3>
                        <ul class="enhanced-list">
                            <li>Screening for substance use</li>
                            <li>Providing interventions and treatment when needed</li>
                            <li>Treating substance use disorders, including pharmacological and psychological interventions</li>
                            <li>Providing family planning assistance for families with substance use disorders (including postpartum and between pregnancies)</li>
                            <li>Establishing prevention programmes to reduce substance use in adolescents</li>
                        </ul>

                        <h3>Tobacco use</h3>
                        <ul class="enhanced-list">
                            <li>Screening of women and girls for tobacco use (smoking and smokeless tobacco) at all clinical visits using "5 As" (ask, advise, assess, assist, arrange)</li>
                            <li>Providing brief tobacco cessation advice, pharmacotherapy (including nicotine replacement therapy, if available) and intensive behavioral counselling services</li>
                            <li>Screening of all non-smokers (men and women) and advising about harm of second-hand smoke and harmful effects on pregnant women and unborn children</li>
                        </ul>

                        <h3>Vaccine-preventable diseases</h3>
                        <ul class="enhanced-list">
                            <li>Vaccination against rubella</li>
                            <li>Vaccination against tetanus and diphtheria</li>
                            <li>Vaccination against Hepatitis B</li>
                        </ul>

                        <h3>Female genital mutilation (FGM)</h3>
                        <ul class="enhanced-list">
                            <li>Discussing and discouraging the practice with the girl and her parents and/ or partner</li>
                            <li>Screening women and girls for FGM to detect complications</li>
                            <li>Informing women and couples about complications of FGM and about access to treatment</li>
                            <li>Carrying out defibulation of infibulated or sealed girls and women before or early in pregnancy</li>
                            <li>Removing cysts and treating other complications</li>
                        </ul>
                    </div>
                </section>
                <!-- END: package-of-care -->

                <!-- START: protocol -->
                <section id="protocol" class="content-section">
                    <h2>Preconception Care Protocol</h2>
                    <div class="content-card">
                        <h3>History taking</h3>
                        <p>Should be comprehensive and include:</p>
                        <ul class="enhanced-list">
                            <li>Family history: hereditary conditions, Medical conditions, congenital abnormalities</li>
                            <li>Medical history: Diabetes, Hypertension, HIV, TB, RT cancers e.g., Breast Cancer, cervical cancer</li>
                            <li>Surgical history: Previous myomectomy, C/section, Obstetric fistula repair</li>
                            <li>Obstetric/gynaecological history: Pregnancy wastage, previous preterm deliveries, STI/RTI, menstrual disorders, prolonged sub fertility</li>
                            <li>Environmental history: exposure to radiation, Chemical</li>
                            <li>Occupational history: type of work and length of working hours as in long distance drivers, athletes, bicycle riders.</li>
                            <li>Nutritional history: diet</li>
                            <li>Male partner history: mumps, STIs/HIV, substance abuse, tight clothing (around scrotum)</li>
                        </ul>

                        <h3>Physical examination</h3>
                        <p>This should encompass a general examination (head to toe) to include vital signs, weight etc.</p>
                        <p>The systemic examination of the thyroid, heart, breasts, abdomen, pelvis and other relevant systems will be based on the history obtained from the woman</p>

                        <h3>Investigations</h3>
                        <p>Minimum investigations should include: Full Blood Count, Random Blood Sugar, syphilis test, HIV test, blood group and rhesus, urinalysis.</p>
                        <p>Additional investigations are based on the history and examination</p>
                        <ul class="enhanced-list">
                            <li>Health education and counselling</li>
                            <li>Psychosocial counselling</li>
                            <li>Family planning: Each woman, man, and couple should be encouraged to have a reproductive life plan including healthy timing and spacing of pregnancy</li>
                            <li>Lifestyle issues</li>
                            <li>Nutrition: Assess dietary status and advice on healthy nutrition.</li>
                            <li>Weight: Check BMI, advise on weight gain or loss where BMI in &lt;20 or &gt;30</li>
                            <li>Substance abuse such as alcohol, hard drugs, tobacco, traditional medications, herbs</li>
                            <li>Timing of intercourse: Check that the couple understands the ovulatory cycle and can determine the most fertile days relative to the woman's cycle. Advice that for conception to occur, intercourse should occur regularly (two to three times a week and should cover the most fertile time.)</li>
                            <li>Regular exercises</li>
                            <li>Adequate rest</li>
                            <li>Prenatal diagnosis: Educate women about options for prenatal diagnosis including genetic counselling (Down's syndrome, sickle cell disease, thalassemia, medical conditions); and virologic screening (TORCHES)</li>
                            <li>Discourage over the counter drugs and use of teratogenic medications</li>
                        </ul>

                        <h3>Other Specific interventions</h3>
                        <ul class="enhanced-list">
                            <li>Prophylaxis Folic Acid - Women who are trying to conceive should take folic acid supplements (400mcg) daily to reduce the risk of neural tube defects. This should begin 3 months before pregnancy. Women with a history of neural tube defects or epilepsy should take 5 mg daily.</li>
                            <li>Iron, Zinc, Vitamin A 10,000 IU, Iodine and Calcium may be taken during the preconception period depending on the health status of the patient and any underlying medical conditions or risks.</li>
                            <li>Management of Pre-existing medical problems:
                                <ul>
                                    <li>Stabilize medical conditions and ensure that medical control is optimal</li>
                                    <li>Check that any drugs or treatments used are safe for use in pregnancy and do not affect sperm function (cytotoxic and radiation, smoking and alcohol etc.)</li>
                                    <li>Where appropriate, refer women for specialized care.</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: protocol -->

                <!-- START: checklist -->
                <section id="checklist" class="content-section">
                    <h2>Preconception Care Checklist</h2>
                    <div class="content-card">
                        <h3>Diet</h3>
                        <ul class="enhanced-list">
                            <li>Nutritional requirements including folic acid supplementation</li>
                            <li>Advice on a healthy diet</li>
                        </ul>

                        <h3>Weight</h3>
                        <ul class="enhanced-list">
                            <li>Measurement of body mass index and appropriate advice</li>
                        </ul>

                        <h3>Exercise</h3>
                        <ul class="enhanced-list">
                            <li>Advise 150 minutes of exercise per week or 30 minutes on most days</li>
                        </ul>

                        <h3>Pregnancy history</h3>
                        <ul class="enhanced-list">
                            <li>Screen for any modifiable risk factors</li>
                        </ul>

                        <h3>Genetic screening</h3>
                        <ul class="enhanced-list">
                            <li>If indicated from personal/family history or ethnic background</li>
                        </ul>

                        <h3>Smoking/alcohol/illicit drugs</h3>
                        <ul class="enhanced-list">
                            <li>Assess of intake and provide appropriate advice</li>
                        </ul>

                        <h3>Psychosocial aspects</h3>
                        <ul class="enhanced-list">
                            <li>Screen for sexual and gender-based violence</li>
                            <li>Screen for mental health conditions</li>
                        </ul>

                        <h3>Medical conditions</h3>
                        <p>eg. cardiac disease, hypertension, diabetes, hypo or hyperthoridism, asthma, HIV/STI's, asthma, sickle cell disease, Rh incompatibility</p>
                        <ul class="enhanced-list">
                            <li>Review current disease status and medications</li>
                            <li>Referral/correspondence with specialist if required</li>
                        </ul>

                        <h3>Environmental</h3>
                        <ul class="enhanced-list">
                            <li>Assess work, home and recreational environments</li>
                        </ul>

                        <h3>Contraception/family planning</h3>
                        <ul class="enhanced-list">
                            <li>Offer appropriate contraception advice for those not desiring pregnancy</li>
                        </ul>

                        <h3>Breast examination</h3>

                        <h3>Dental health check</h3>

                        <h3>Screening for sexually transmissible infections and other infectious diseases</h3>
                        <ul class="enhanced-list">
                            <li>Measles, mumps, rubella, varicella zoster, hepatitis B</li>
                            <li>Human immunodeficiency virus and hepatitis C with appropriate pre-test counselling</li>
                            <li>Cervical screening</li>
                        </ul>
                    </div>
                </section>
                <!-- END: checklist -->

                <!-- START: antenatal-care -->
                <section id="antenatal-care" class="content-section">
                    <h1 class="section-title">ANTENATAL CARE</h1>
                    <div class="content-card">
                        <h2>Introduction</h2>
                        <p>Antenatal care offers a great opportunity to prevent and manage existing and potential causes of maternal and neonatal morbidity and mortality. The new 2016 WHO ANC model advocates for 8 contacts with the first occurring within the first trimester.</p>
                        <p>Definition- Antenatal care (ANC) can be defined as the care provided by skilled health-care professionals to pregnant women and adolescent girls in order to ensure the best health conditions /outcomes for both mother and baby during pregnancy. The components of ANC include: risk identification; prevention and management of pregnancy-related or concurrent diseases; and health education and health promotion.</p>

                        <h2>Epidemiology</h2>
                        <p>Only 50% of women worldwide receive the recommended amount of care during pregnancy. Globally, while 86% of pregnant women access antenatal care with skilled health personnel at least once, only three in five (62%) receive at least four antenatal visits. In regions with the highest rates of maternal mortality, such as Sub-Saharan Africa and South Asia, even fewer women receive at least four antenatal visits (52% and 46%, respectively).</p>
                        <p>History of Antenatal Care - In 2002, the WHO recommended a focused or goal-orientated approach to ANC to enhance the quality of care and increase ANC coverage, especially in LMICs. The focused ANC (FANC) model entailed four ANC visits occurring between 8 and 12 weeks of gestation, between 24 and 26 weeks, at 32 weeks, and between 36 and 38 weeks. Guidance on each visit included specific evidence-based interventions for healthy pregnant women with appropriate referral of high-risk women and those who develop pregnancy complications.</p>
                        <p>On November 7th, 2016, the World Health Organization released its comprehensive recommendations on routine ANC for pregnant women and adolescent girls and this model entailed 8 visits.</p>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 13: Comparison of the FANC model and new 2016 WHO ANC model</caption>
                                <thead>
                                    <tr>
                                        <th>WHO FANC model</th>
                                        <th>2016 WHO ANC model</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td colspan="2" style="text-align:center; font-weight:bold;">First trimester</td></tr>
                                    <tr><td>Visit 1: 8-12 weeks</td><td>Contact 1: up to 12 weeks</td></tr>
                                    <tr><td colspan="2" style="text-align:center; font-weight:bold;">Second trimester</td></tr>
                                    <tr><td>Visit 2: 24-26 weeks</td><td>Contact 2: 20 weeks<br>Contact 3: 26 weeks</td></tr>
                                    <tr><td colspan="2" style="text-align:center; font-weight:bold;">Third trimester</td></tr>
                                    <tr><td>Visit 3: 32 weeks</td><td>Contact 4: 30 weeks<br>Contact 5: 34 weeks<br>Contact 6: 36 weeks<br>Contact 7: 38 weeks<br>Contact 8: 40 weeks</td></tr>
                                    <tr><td>Visit 4: 36-38 weeks</td><td></td></tr>
                                    <tr><td colspan="2" style="text-align:center;">Return for delivery at 41 weeks if not given birth.</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 14: Key recommendations of the new 2016 WHO ANC model</caption>
                                <thead>
                                    <tr>
                                        <th>No.</th>
                                        <th>Interventions</th>
                                        <th>Recommendations</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>A</td>
                                        <td>Nutritional interventions</td>
                                        <td>
                                            <ul>
                                                <li>Counselling about healthy eating and keeping physically active during pregnancy is recommended for pregnant women to stay healthy and to prevent excessive weight gain during pregnancy.</li>
                                                <li>In undernourished populations, nutrition education on increasing daily energy and protein intake is recommended for pregnant women to reduce the risk of low-birth-weight neonates</li>
                                                <li>In undernourished populations, balanced energy and protein dietary supplementation is recommended for pregnant women to reduce the risk of stillbirths and small-for-gestational-age neonates.</li>
                                                <li>Daily oral iron and folic acid supplementation with 60 mg to 65 mg of elemental iron and 400 mcg (0.4 mg) of folic acid is recommended for pregnant women to prevent maternal anemia, puerperal sepsis, low birth weight, and preterm birth</li>
                                            </ul>
                                            <p>NB: Health care providers should counsel the clients on the benefits of iron and folic acid during pregnancy to help enhance adherence.</p>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>B</td>
                                        <td>Maternal and fetal assessment</td>
                                        <td>
                                            <ul>
                                                <li>Full blood count testing is the recommended method for diagnosing anaemia in pregnancy. In settings where full blood count testing is not available, on-site haemoglobin testing with a haemoglobinometer is recommended over the use of the haemoglobin color scale as the method for diagnosing anaemia in pregnancy</li>
                                                <li>Health-care providers should ask all pregnant women about their use of alcohol and other substances (past and present) as early as possible in the pregnancy and at every antenatal care visit.</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>C</td>
                                        <td>Fetal assessment</td>
                                        <td>
                                            <ul>
                                                <li>One ultrasound scan before 24 weeks of gestation (early ultrasound) is recommended for pregnant women to estimate gestational age, improve detection of fetal anomalies and multiple pregnancies.</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>D</td>
                                        <td>Preventive Measures</td>
                                        <td>
                                            <ul>
                                                <li>Antenatal prophylaxis with anti-D immunoglobulin in non-sensitized Rh-negative pregnant women at 28 and 34 weeks of gestation to prevent RhD alloimmunization</li>
                                                <li>Preventive anthelminthic treatment is recommended for pregnant women after the first trimester as part of worm infection reduction programmes.</li>
                                                <li>In malaria-endemic areas, intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) is recommended for all pregnant women. Dosing should start in the second trimester, and doses should be given at least one month apart, with the objective of ensuring that at least three doses are received.</li>
                                                <li>Oral pre-exposure prophylaxis (PrEP) containing tenofovir disoproxil fumarate (TDF) should be offered as an additional prevention choice for pregnant women at substantial risk of HIV infection as part of combination prevention approaches</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>E</td>
                                        <td>Health systems interventions to improve the utilization and quality of antenatal care</td>
                                        <td>
                                            <ul>
                                                <li>Each pregnant woman carries her own case notes during pregnancy to improve continuity, quality of care and her pregnancy experience.</li>
                                                <li>Midwife-led continuity-of-care models, in which a known midwife or small group of known midwives supports a woman throughout the antenatal, intrapartum and postnatal continuum, are recommended for pregnant women in settings with well-functioning midwifery programmes (Context-specific recommendation)</li>
                                                <li>Group antenatal care provided by qualified health-care professionals may be offered as an alternative to individual antenatal care for pregnant women in the context of rigorous research, depending on a woman's preferences and provided that the infrastructure and resources for delivery of group antenatal care are available (Context-specific recommendation (research)</li>
                                                <li>Packages of interventions that include household and community mobilization and antenatal home visits are recommended to improve antenatal care utilization and perinatal health outcomes, particularly in rural settings with low access to health services (Context-specific recommendation)</li>
                                                <li>Task sharing the promotion of health-related behaviours for maternal and newborn health to a broad range of cadres, including lay health workers, auxiliary nurses, nurses, midwives and doctors is recommended.</li>
                                                <li>Policy-makers should consider educational, regulatory, financial, and personal and professional support interventions to recruit and retain qualified health workers in rural and remote areas.</li>
                                                <li>Antenatal care models with a minimum of eight contacts are recommended to reduce perinatal mortality and improve women's experience of care.</li>
                                            </ul>
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Justification of the new 2016 ANC Model</h3>
                        <p>This guideline recommendation was informed by:</p>
                        <ul class="enhanced-list">
                            <li>Evidence suggesting increased perinatal deaths in 4-visit ANC model</li>
                            <li>Evidence supporting improved safety during pregnancy through increased frequency of maternal and fetal assessment to detect complications</li>
                            <li>Evidence supporting improved health system communication and support around pregnancy for women and families</li>
                            <li>Evidence indicating that more contact between pregnant women and respectful, knowledgeable health care workers is more likely to lead to a positive pregnancy experience.</li>
                            <li>Evidence from HIC studies indicating no important differences in maternal and perinatal health outcomes between ANC models that included at least eight contacts and ANC models that included 11 to 15 contacts</li>
                        </ul>
                        <p>NB: As comprehensive as the current recommendations are, the guideline development process also identified several knowledge gaps such as antenatal screening of gestational diabetes mellitus and future updates will also aim at including more extensive health system-level recommendations on how to improve utilization and quality of antenatal care</p>

                        <h3>Summary of the 2016 ANC Guidelines</h3>
                        <p>49 recommendations are grouped into five topic areas:</p>
                        <ul class="enhanced-list">
                            <li>Nutritional interventions (14)</li>
                            <li>Maternal and fetal assessment (13)</li>
                            <li>Preventive measures (7)</li>
                            <li>Interventions for common physiological symptoms (6)</li>
                            <li>Health systems interventions to improve the utilization and quality of ANC (9)</li>
                        </ul>
                        <p>Antenatal care models with a minimum of eight contacts are recommended to reduce perinatal mortality and improve women's experience of care. There are five contacts in the third trimester, one contact in the first trimester, and two contacts in the second trimester. The new model recommends pregnant women to have their first contact during the first 12 weeks' gestation, with following contacts taking place at 20, 26, 30, 34, 36, 38 and 40 weeks of gestation.</p>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 15: Summary of the 2016 WHO ANC Model</caption>
                                <thead>
                                    <tr>
                                        <th>Contacts</th>
                                        <th>Weeks</th>
                                        <th>Services</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td colspan="3" style="text-align:center; font-weight:bold;">First Trimester</td></tr>
                                    <tr>
                                        <td>Contact 1</td>
                                        <td>Up to 12 weeks</td>
                                        <td>
                                            <ul>
                                                <li>Baseline investigations on 1st visit:
                                                    <ul>
                                                        <li>FBC and Blood grouping</li>
                                                        <li>Urinalysis/Midstream urine culture</li>
                                                        <li>Random blood glucose</li>
                                                        <li>HIV testing and TB screening</li>
                                                        <li>Syphilis screening (VDRL/RPR)</li>
                                                    </ul>
                                                </li>
                                                <li>Early obstetric ultrasound (determine if pregnancy is intra or extrauterine)</li>
                                                <li>History and clinical examination</li>
                                                <li>Education on danger signs, nutrition, breastfeeding, hygiene and common symptoms encountered during pregnancy</li>
                                                <li>Nutritional supplementation- folic acid, iron and calcium supplementation</li>
                                                <li>BP measurement and weight measurement during each contact *Hb to be taken once in each trimester - contextualized</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr><td colspan="3" style="text-align:center; font-weight:bold;">Second Trimester</td></tr>
                                    <tr>
                                        <td>Contact 2</td>
                                        <td>20 weeks</td>
                                        <td>
                                            <ul>
                                                <li>Early obstetric ultrasound at <strong>18-20 weeks</strong></li>
                                                <li>IPTs-SP from 13 weeks, 4 weeks apart until delivery in malaria endemic areas.</li>
                                                <li>Deworming using Mebendazole 500 mg</li>
                                                <li>* Hb to be taken once in each trimester - contextualized</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>Contact 3</td>
                                        <td>26 weeks</td>
                                        <td>
                                            <ul>
                                                <li>ICT (Indirect Coombs Test) for Rh-ve mothers prior to anti-D administration</li>
                                                <li>Prophylactic anti-D at 28 weeks for Rh-ve women</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr><td colspan="3" style="text-align:center; font-weight:bold;">Third Trimester</td></tr>
                                    <tr><td>Contact 4</td><td>30 weeks</td><td></td></tr>
                                    <tr><td>Contact 5</td><td>34 weeks</td><td></td></tr>
                                    <tr>
                                        <td>Contact 6</td>
                                        <td>36 weeks</td>
                                        <td>
                                            <ul>
                                                <li>Clinical examination; obstetric abdominal examination and risk assessment</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>Contact 7</td>
                                        <td>38 weeks</td>
                                        <td>
                                            <ul>
                                                <li>*Hb to be taken once in each trimester - contextualized</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr><td>Contact 8</td><td>40 weeks</td><td></td></tr>
                                    <tr><td colspan="3" style="text-align:center; font-weight:bold;">RETURN AT 41 WEEKS IF LABOUR HAS NOT COMMENCED</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>GROUP ANC</h3>
                        <p>This is an alternative model. ANC conventionally takes the form of a one-on-one consultation between a pregnant woman and her health-care provider. Group ANC (GANC) integrates the usual individual pregnancy health assessment with tailored group educational activities and peer support, with the aim of motivating behavior change among pregnant women, improving pregnancy outcomes, and increasing women's satisfaction.</p>
                        <p>Group ANC needs to be delivered in a space large enough to accommodate a group of pregnant women based on the gestational ages, with a private area for examinations.</p>
                        <p>The intervention typically involves:</p>
                        <ul class="enhanced-list">
                            <li>Self-assessment activities (e.g., Blood pressure measurement)</li>
                            <li>Group education with facilitated discussion</li>
                            <li>Socialization activities</li>
                        </ul>
                        <p>Group antenatal care provided by qualified health-care professionals may be offered as an alternative to individual antenatal care for pregnant women in the context of rigorous research, depending on a woman's preferences and provided that the infrastructure and resources for delivery of group antenatal care are available.</p>
                        <p>Group care studies conducted in Kenya and Nigeria showed improved quality of ANC. Patient and provider experience was more satisfactory with group care. There was more empowerment and self-efficacy with the pregnancy, newborn care, postpartum family planning and healthier outcomes.</p>

                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-078-1.jpg" alt="Figure 13: GANC Model" class="content-image">
                            <figcaption>Figure 13: GANC Model</figcaption>
                        </figure>

                        <h3>IMPLEMENTING GANC: ROLLING OUT THE MODEL BASED ON WHO 8 CONTACTS RECOMMENDATIONS</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <tbody>
                                    <tr><td><strong>1ST. CONTACT</strong></td><td>8 to12 weeks<br>Physical exam and Full history, ANC profile<br>Recruitment into the group</td></tr>
                                    <tr><td><strong>2ND. CONTACT</strong></td><td>Up to 20 Weeks<br>Importance and components of ANC<br>IFAS discussion, Home self-care</td></tr>
                                    <tr><td><strong>3RD. CONTACT</strong></td><td>Up to 26 weeks<br>Danger signs during pregnancy<br>Importance of facility delivery, Group-Self-care</td></tr>
                                    <tr><td><strong>4TH. CONTACT</strong></td><td>Up to 30 weeks<br>Individual Birth plans<br>Danger signs continued<br>Importance of exclusive breastfeeding, Self care activities</td></tr>
                                    <tr><td><strong>5TH. CONTACT</strong></td><td>Up to 34 weeks<br>Care of the newbor<br>Breastfeeding-early initiatio positioning and attachment, PPFP, Self-care activities</td></tr>
                                    <tr><td><strong>6TH. CONTACT</strong></td><td>Up to 36 weeks<br>Kangaroo mother care<br>Thermal care of the newborn, CHX Cord care</td></tr>
                                    <tr><td><strong>7TH. CONTACT</strong></td><td>Up to 38 weeks<br>Signs of labour<br>Recap essential newborn care, Group-Self-care activities</td></tr>
                                    <tr><td><strong>8TH. CONTACT</strong></td><td>Up to 40 weeks<br>Signs of labour, Labour exercise<br>PPFP, Recap essential newborn care</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-080-1.jpg" alt="Figure 14: Outcomes to track during Group ANC" class="content-image">
                            <figcaption>Figure 14: Outcomes to track during Group ANC</figcaption>
                        </figure>

                        <h3>Advantages</h3>
                        <ul class="enhanced-list">
                            <li>Reducing health inequalities by improving health literacy among less-educated women.</li>
                            <li>Providing social support. The flexibility of the format allows women to exchange valuable information with each other and discuss pregnancy-related concerns in a relaxed and informal manner</li>
                            <li>Improving maternal and neonatal outcomes</li>
                            <li>Enhances the move towards the 8 -contact model</li>
                            <li>Resources are effectively put into good use</li>
                        </ul>

                        <h3>Disadvantages</h3>
                        <ul class="enhanced-list">
                            <li>Group ANC may take longer than individual ANC, and this may pose practical problems for some women in terms of work and childcare.</li>
                            <li>In settings with poor transport systems or variable weather, the appointment system with group ANC may not be suitable and may have a negative impact on equity for women living in remote areas.</li>
                            <li>Group ANC may have acceptability and feasibility issues in settings where perceived differences keep people apart, e.g. women from different castes in India may not wish to be in a group together.</li>
                        </ul>
                        <p>Health-care facilities need to be seeing sufficient numbers of pregnant women, as allocation to groups is ideally performed according to gestational age.</p>

                        <h3>Recommendations and Conclusions (ACOG 2018)</h3>
                        <p>The American College of Obstetricians and Gynecologists makes the following recommendations:</p>
                        <ul class="enhanced-list">
                            <li>Group prenatal care models are designed to improve patient education and include opportunities for social support while maintaining the risk screening and physical assessment of individual prenatal care.</li>
                            <li>Studies appear to demonstrate high levels of patient satisfaction, obstetric outcomes equally efficacious as individual prenatal care, and improved outcomes for some populations.</li>
                            <li>Specific group prenatal care models can be challenging to initiate and maintain. The cost of initiating a group prenatal care model in current obstetric practices may be a barrier to implementation.</li>
                        </ul>

                        <h3>Preventive measures during pregnancy</h3>
                        <p><strong>IFAS:</strong> When anemia in pregnancy (hemoglobin level less than 11g/dl) is diagnosed, the dose of elemental iron should be increased to 120 mg until the Hb concentration rises to normal or higher.</p>
                        <p><strong>Vitamin A:</strong> Vitamin A supplementation is not recommended to improve maternal or perinatal outcomes unless in areas where Vitamin A deficiency is considered a significant public health problem. When indicated Vitamin A is given daily or weekly (up to 10,000 IU per day or weekly dose of up to 25,000 IU) to prevent night blindness.</p>
                        <p><strong>Tetanus Diphtheria (TD) vaccination:</strong></p>
                        <ul class="enhanced-list">
                            <li>If a pregnant woman has not been previously vaccinated, or her immunization status is unknown, she should receive two doses of TD vaccine one month apart with the second dose given at least 2 weeks before delivery/childbirth. 2 doses protect against TD infection for 13 years. A third dose is recommended six months after the second dose, which should extend protection to at least 5 years.</li>
                            <li>Two further doses for women who are first vaccinated against TD during pregnancy should be given after the third dose, in the two subsequent years or during two subsequent pregnancies.</li>
                            <li>If a woman has had 1-4 TD injections in the past, she should receive one dose of TT during each subsequent pregnancy to a total of 5 doses (5 doses offer protection throughout the childbearing years).</li>
                        </ul>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 16: Tetanus Toxoid injection schedule</caption>
                                <thead>
                                    <tr>
                                        <th>Tetanus Toxoid injection</th>
                                        <th>Time given</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td>1st injection</td><td>During pregnancy first visit</td></tr>
                                    <tr><td>2nd injection</td><td>4 weeks after 1st dose but 2 weeks before delivery</td></tr>
                                    <tr><td>3rd injection</td><td>6 months after 2nd dose</td></tr>
                                    <tr><td>4th injection</td><td>1 year after 3rd injection/ subsequent pregnancy</td></tr>
                                    <tr><td>5th injection</td><td>1 year after 4th injection/ subsequent pregnancy</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <p><strong>IPTp:</strong> Intermittent preventive treatment with Sulfadoxine pyrimethamine (IPTp-SP) is recommended for all pregnant women living in the malaria endemic areas. Dosing should start in the second trimester (13 weeks) and be given at least one month apart; with the objective of ensuring that at least three doses are received.</p>
                        <p>The National guidelines on Malaria prevention - start at 13 weeks, monthly till delivery. HIV positive mothers on Cotrimoxazole should not take IPT.</p>
                        <p><strong>Deworming:</strong> Preventive chemotherapy (deworming), using single-dose albendazole (400 mg) or mebendazole (500 mg) is recommended as a public health intervention for pregnant women living in hook-worm infested areas from the 2nd trimester. (WHO, 2016)</p>

                        <h3>Ancillary ANC Investigations as Per Facility Level</h3>
                        <p>Additional investigations that can be done prenatally include:</p>
                        <ul class="enhanced-list">
                            <li>Chlamydia: Selective testing for Chlamydia should be considered for those who may be at increased risk according to local prevalence.</li>
                            <li>Hepatitis B serology: Women found to be chronic carriers of Hepatitis B, should have an assessment of their viral replicative status (i.e. HBV DNA level and HBe antigen status) and liver function performed, and be referred for specialist support.</li>
                            <li>Hepatitis C serology: Women who are known to be Hepatitis C antibody positive should have liver function tests performed and an assessment of their viral load (Hepatitis C RNA PCR).I Consider referral to an appropriate specialist for counseling and planning postnatal follow up.</li>
                            <li>Varicella: Consideration should be given to checking varicella antibodies at the first visit where there is no definite history of chickenpox.</li>
                            <li>Cervical screening: Cervical screening for HPV/dysplasia should be recommended at the first antenatal visit if this would fall due during the pregnancy, according to cervical screening guidelines.</li>
                            <li>Screening for Down syndrome: Chorionic venous sampling and amniocentesis</li>
                            <li>Screening for haemoglobinopathies: Hemoglobin electrophoresis (HbEPG) or highperformance liquid chromatography (HPLC) and exclusion of iron deficiency (ferritin level) should be performed in the event of low MCV. Full assessment of fetal risk requires investigation of the partner.</li>
                            <li>Vitamin D: Gravid women at risk for vitamin D deficiency should be tested in early pregnancy or provided with vitamin D supplementation.</li>
                            <li>Cytomegalovirus (CMV): Routine serological screening for CMV infection in pregnancy is not recommended.</li>
                            <li>Toxoplasmosis: Routine serological screening for toxoplasmosis infection in pregnancy is not recommended.</li>
                            <li>Thyroid function tests (Serum TSH assessment): Routine screening for subclinical thyroid disease remains controversial. Screening for thyroid dysfunction to be considered for at risk groups.</li>
                            <li>Group B Strep status (GBS) and gonorrhea screening (first catch urine or self-applied swab)</li>
                            <li>Rubella titres</li>
                            <li>Vaginal fluid fibronectin, Nitrazine test and Ferning test to evaluate for premature rupture of membranes.</li>
                            <li>Gestational diabetes in women at risk: OGTT (If high risk OGTT (preferred) or HbAIc at 5-12 weeks). Fasting -For high risk 1-2-hour HbAIc (1st trimester only)</li>
                        </ul>

                        <h3>The Mandatory ANC Profile</h3>
                        <ul class="enhanced-list">
                            <li>TB</li>
                            <li>HIV</li>
                            <li>VDRL</li>
                            <li>Blood sugars</li>
                            <li>Full hemogram</li>
                            <li>BS for malaria</li>
                            <li>Blood group and rhesus factor</li>
                            <li>Urinalysis</li>
                        </ul>

                        <h3>HIGH RISK PREGNANCIES</h3>
                        <ul class="enhanced-list">
                            <li>A high-risk pregnancy defined as one which is complicated by factor or factors that adversely affects the pregnancy outcome (maternal, perinatal or both).</li>
                            <li>Several factors can make a pregnancy high risk, including existing health conditions, the mother's age, lifestyle, and health issues that happen before or during pregnancy.</li>
                            <li>High-risk pregnancy can have serious maternal, obstetric, and neonatal complications if left undetected.</li>
                        </ul>
                        <p>NB: Pregnancy itself predisposes the client and puts the client at health risk.</p>

                        <h3>Classification of high-risk pregnancies</h3>
                        <ul class="enhanced-list">
                            <li>Pre-existing health conditions: Hypertension, Diabetes mellitus, sexually transmitted diseases, Renal disorders, Thyroid disorders, Autoimmune diseases, Acute surgical problems, genital tract abnormalities, Obesity, Hemoglobinopathies, Severe anemia (Hb &lt;7g/dl)</li>
                            <li>Age: Young (adolescent pregnancy), Advanced maternal age</li>
                            <li>Lifestyle factors: Alcohol abuse, Tobacco smoking, illicit drug use,</li>
                            <li>Conditions of pregnancy: Multifetal gestation, Gestational diabetes mellitus, Pre-eclampsia, previous preterm delivery, previous stillbirth, birth defects or genetic conditions in the fetus, placental anomalies, premature rupture of membranes, polyhydramnios, oligohydramnios, prior birth trauma, late spontaneous abortion.</li>
                        </ul>
                        <p>Management and prevention is tailored to the specific pre-existing medical disorder or risk factor. For instance, in a woman suffering from hyperthyroidism, antithyroid drugs would be useful in mitigating against complications that may arise in pregnancy and thus lead to favorable maternal and neonatal outcomes.</p>
                        <p>Risk assessment in pregnancy helps to predict which women are most likely to experience adverse health events and enables providers to administer risk-appropriate perinatal care.</p>
                        <p>Effective communication, control and early detection are important tools that doctors must be able to use to plan the best treatment strategies and to minimize the risks of maternal and / or fetal.</p>

                        <h3>Individual Birth Plan (IBP)</h3>
                        <p><strong>Women at low risk of complications</strong></p>
                        <ul class="enhanced-list">
                            <li>Explain to both multiparous and nulliparous women who are at low risk of complications that giving birth is generally very safe for both the woman and her baby.</li>
                            <li>Explain to low-risk nulliparous women that:
                                <ul>
                                    <li>Planned births need to be under skilled birth atrendance</li>
                                    <li>When discussing the woman's choice of place of birth with her, do not disclose personal views or judgements about her choices.</li>
                                </ul>
                            </li>
                            <li>Explain to both multiparous and nulliparous women that they may choose any birth setting support them in their choice of setting wherever they choose to give birth.</li>
                            <li>Advise low-risk nulliparous women that they should have emergency preparedness as medical or obstetric complications can arise necessitating referral.</li>
                        </ul>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 17: Conditions indicating increased risk suggesting planned birth at a Health facility</caption>
                                <thead>
                                    <tr>
                                        <th>Disease area</th>
                                        <th>Medical condition</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td>Cardiovascular</td><td>Confirmed cardiac disease<br>Hypertensive disorders</td></tr>
                                    <tr><td>Respiratory</td><td>Asthma requiring an increase in treatment or hospital treatment<br>Cystic fibrosis</td></tr>
                                    <tr><td>Haematological</td><td>Haemoglobinopathies - sickle-cell disease, beta-thalassaemia major<br>History of thromboembolic disorders<br>Immune thrombocytopenia purpura or other platelet disorder or platelet count below 100 x 109/litre<br>Von Willebrand's disease<br>Bleeding disorder in the woman or unborn baby<br>Atypical antibodies which carry a risk of haemolytic disease of the new-born</td></tr>
                                    <tr><td>Endocrine</td><td>Hyperthyroidism<br>Diabetes</td></tr>
                                    <tr><td>Infective</td><td>Risk factors associated with group B streptococcus whereby antibiotics in labour would be recommended<br>Hepatitis B/C with abnormal liver function tests<br>Carrier of/infected with HIV<br>Toxoplasmosis - women receiving treatment<br>Current active infection of chicken pox/rubella/genital herpes in the woman or baby<br>Tuberculosis under treatment</td></tr>
                                    <tr><td>Immune</td><td>Systemic lupus erythematosus<br>Scleroderma</td></tr>
                                    <tr><td>Renal</td><td>Abnormal renal function<br>Renal disease requiring supervision by a renal specialist</td></tr>
                                    <tr><td>Neurological</td><td>Epilepsy<br>Myasthenia gravis<br>Previous cerebrovascular accident</td></tr>
                                    <tr><td>Gastrointestinal</td><td>Liver disease associated with current abnormal liver function tests</td></tr>
                                    <tr><td>Psychiatric</td><td>Psychiatric disorder requiring current inpatient care</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Other factors indicating increased risk suggesting planned birth at a Health facility</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Factor</th>
                                        <th>Additional information</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td>Previous complications</td><td>Unexplained stillbirth/neonatal death or previous death related to intrapartum difficulty<br>Previous baby with neonatal encephalopathy<br>Pre-eclampsia requiring preterm birth<br>Placental abruption with adverse outcome<br>Eclampsia<br>Uterine rupture<br>Primary PPH requiring additional treatment or blood transfusion<br>Retained placenta requiring manual removal in theatre<br>Caesarean section<br>Shoulder dystocia</td></tr>
                                    <tr><td>Current pregnancy</td><td>Multiple birth<br>Placenta praevia<br>Pre-eclampsia or pregnancy-induced hypertension<br>Preterm labour or preterm prelabour rupture of membranes<br>Placental abruption<br>Anaemia - haemoglobin less than 85 g/decilitre at onset of labour<br>Confirmed intrauterine death<br>Induction of labour<br>Substance misuse<br>Alcohol dependency requiring assessment or treatment<br>Onset of gestational diabetes<br>Malpresentation - breech or transverse lie<br>BMI at booking of greater than 35 kg/m¬≤<br>Recurrent antepartum haemorrhage<br>Small for gestational age in this pregnancy (less than fifth centile or reduced growth velocity on ultrasound)<br>Abnormal fetal heart rate/doppler studies<br>Ultrasound diagnosis of oligo-/polyhydramnios</td></tr>
                                    <tr><td>Previous gynaecological history</td><td>Myomectomy<br>Hysterectomy</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Other factors indicating individual assessment when planning place of birth</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Factor</th>
                                        <th>Additional information</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td>Previous complications</td><td>Stillbirth/neonatal death with a known nonrecurrent cause<br>Pre-eclampsia developing at term<br>Placental abruption with good outcome<br>History of previous baby more than 4.5 kg<br>Extensive vaginal, cervical, or third- or fourthdegree perineal trauma<br>Previous term baby with jaundice requiring exchange transfusion</td></tr>
                                    <tr><td>Current pregnancy</td><td>Antepartum bleeding of unknown origin (single episode after 24 weeks of gestation)<br>BMI at booking of 30-35 kg/m¬≤<br>Blood pressure of 140 mmHg systolic or 90 mmHg diastolic or more on 2 occasions<br>Clinical or ultrasound suspicion of macrosomia<br>Para 4 or more<br>Recreational drug use<br>Under current outpatient psychiatric care<br>Age over 35 at booking</td></tr>
                                    <tr><td>Fetal indications</td><td>Fetal abnormality</td></tr>
                                    <tr><td>Previous gynaecological history</td><td>Major gynaecological surgery<br>Cone biopsy or large loop excision of the transformation zone<br>Fibroids</td></tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>RESPECTFUL MATERNITY CARE (RMC)</h3>
                        <p>Respectful maternity care - which refers to care organized for and provided to all women in a manner that maintains their dignity, privacy and confidentiality, ensures freedom from harm and mistreatment, and enables informed choice and continuous support during labour and childbirth.</p>
                        <p>Respectful maternity care (RMC) is not only a crucial component of quality of care; it is a human right. In 2014, WHO released a statement calling for the prevention and elimination of disrespect and abuse during childbirth, stating that "every woman has the right to the highest attainable standard of health, including the right to dignified, respectful care during pregnancy and childbirth."</p>
                        <p>The aim of RMC is to give total respect and to preserve the dignity of all women throughout their stay in the health facility. Their privacy and confidentiality should be respected at all times, and any kind of mistreatment, such as physical, sexual or verbal abuse, discrimination, neglect, detainment, extortion or denial of services, should be avoided.</p>
                        <p>Effective communication and engagement among health care providers, health service managers, women and representatives of women's groups and women's rights movements is essential to ensure that care is responsive to women's needs and preferences in all contexts and settings.</p>
                        <p>Interventions should aim to ensure a respectful and dignified working environment for those providing care, acknowledging that staff may also experience disrespect and abuse in the workplace and/or violence at home or in the community.</p>
                        <ul class="enhanced-list">
                            <li>All women and newborns have privacy around the time of antenatal, labour/childbirth, and postnatal care and their confidentiality is respected.</li>
                            <li>No woman or newborn is subjected to mistreatment, such as physical, sexual or verbal abuse, discrimination, neglect, detainment, extortion or denial of services.</li>
                            <li>All women can make informed choices about the services they receive, and the reasons for interventions or outcomes are clearly explained.</li>
                        </ul>

                        <h3>MATERNITY OPEN DAYS</h3>
                        <p>This concept was introduced by WHO in 2019 with the aim of public health facilities showcase what services they offer in maternal health and increase facility delivery in order to utilize the free maternal health care services being offered in public health facilities. Targeted to increase antenatal attendance, skilled birth attendance and targeted postnatal care coverage to over 80% by 2030 in order to meet maternal and newborn care indicators of ICPD+25, (2019). This can be achieved through open maternity day in health facilities and community dialogue.</p>
                        <ul class="enhanced-list">
                            <li>During Maternity open day the pregnant mother, her partner, family and the community are provided with an opportunity to visit and tour the maternity unit, meet with obstetricians/gynecologists, midwives and other health care providers.</li>
                            <li>They interact with the health care providers one on one, learn about birth preparedness, choice of birth place and see services offered in maternity. Information on preconception care, breastfeeding, health and wellbeing, Insurance services/Linda mama package, birthing positions, danger signs in pregnancy, nutrition in pregnancy and other services relevant to pregnancy are given.</li>
                            <li>The pregnant mother, her male partner, family and community are taken round the maternity wing to see the environment and equipment available.</li>
                            <li>Maternity open days exist to facilitate birth preparedness and encourage more mothers to deliver in hospitals and also involve the male partner and community in maternal health issues.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: antenatal-care -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">üè†</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="02-maternal-nutrition.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 16%;"></div>
                        </div>
                       <span class="progress-text">Section 3 of 18</span>
                    </div>
                    <a href="04-aph-and-pprom.html" class="nav-button">
                        <span class="nav-text">Next: APH & PPROM</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>